Accenture (NYSE:ACN) was in the spotlight on Friday as UBS upgraded the IT consulting firm, citing its prospects in generative artificial intelligence.
Shares were little changed in premarket trading.
Although there is a concern about the pace of IT spending, where it is going — cloud, digital transformation, cybersecurity and generative AI — should lead to “higher and more durable growth,” UBS analyst Kevin McVeigh wrote in an investor note. McVeigh raised his rating on Accenture to Buy from Neutral and put a $400 price target on the stock.
McVeigh added that generative AI adoption is “poised to accelerate,” and the stock is not reflecting the extent of how big generative AI could be for the company.